Skip to main content
Clinical Trials/EUCTR2018-003863-67-FR
EUCTR2018-003863-67-FR
Active, not recruiting
Phase 1

Multicenter randomized controlled trial on the interest of intravitreal injections of anti-VEGF as initial and adjuvant treatment in Coats disease - COATS-VEGF

Fondation Ophtalmologique Adolphe de Rothschild0 sites30 target enrollmentNovember 28, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Enrollment
30
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 28, 2018
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Patient \= 16 years old
  • \- Coats disease confirmed by fundus examination and fluorescein angiography
  • \- Stage 2 or 3 at the fundus (Shields classification) on at least 2 quadrants
  • \- Naïve to any eye treatment on the eye affected by Coats disease
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 30
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • \- Other ocular pathology on the eye affected by Coats' disease
  • \- Bilateral forms of the disease
  • \- History of hypersensitivity to bevacizumab
  • \- History of hypersensitivity to products of Chinese hamster ovary cells or other recombinant human or humanized antibodies
  • \- Allergic reaction in a previous fluorescein retinal angiogram
  • \- Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials